Viewing Study NCT05249959


Ignite Creation Date: 2025-12-24 @ 2:46 PM
Ignite Modification Date: 2025-12-30 @ 2:10 AM
Study NCT ID: NCT05249959
Status: RECRUITING
Last Update Posted: 2025-08-08
First Post: 2022-02-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Consolidation With Loncastuximab Tesirine After a Short Course of Immunochemotherapy in BTKi-treated (or Intolerant) Relapsed/Refractory Mantle Cell Lymphoma Patients.
Sponsor: Fondazione Italiana Linfomi - ETS
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module